Skip to main content

Advertisement

SpringerLink
Log in

Otitis Media: A Review, with a Focus on Alternative Treatments

  • Published:
Probiotics and Antimicrobial Proteins Aims and scope Submit manuscript

Abstract

Otitis media (OM) is the accumulation of fluids in the middle ear, with or without symptoms of inflammation. The infection is caused by dysfunction or obstruction of the eustachian tube and is most commonly diagnosed in children under the age of two. The microbiology of OM differs, with Streptococcus pneumoniae, non-typeable Haemophilus influenzae and Moraxella catarrhalis the most commonly isolated pathogens. The emergence of penicillin-resistant Strep. pneumoniae, β-lactamase-producing strains, Haem. influenzae and Mor. catarrhalis is a major concern and health care costs associated with treatment are substantial, especially in cases of unresponsive treatment as a result of incorrect diagnosis. Alternative treatments such as vaccines and a nasal spray containing α-haemolytic streptococci with antimicrobial activity against OM pathogens, have been developed. The rationale behind such treatments is to induce an appropriate immune response against the pathogens and decrease bacterial colonisation in the nasopharynx. Another approach may be treatment with bacteriocins (natural antimicrobial peptides) or bacteriocin-like inhibitory substances (BLIS) produced by lactic acid bacteria. We have recently described an antibacterial peptide produced by Enterococcus mundtii ST4SA and have published on bacteriocins (enterocins) with antibacterial and antiviral activity. This review discusses the condition OM, summarises current methods used to treat the infection, and suggests alternative safe and natural treatments that need to be explored.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Abbanat D, Morrow B, Bush K (2008) New agents in development for the treatment of bacterial infections. Curr Opin Pharmacol 8:582–592

    PubMed  CAS  Google Scholar 

  2. Abee T (1995) Pore-forming bacteriocins of Gram-positive bacteria and self-protection mechanisms of producer organisms. FEMS Microbiol Lett 129:1–10

    PubMed  CAS  Google Scholar 

  3. Abee T, Krockel L, Hill C (1995) Bacteriocins: modes of action and potentials in food preservation and control of food poisoning. Int J Food Microbiol 28:169–185

    PubMed  CAS  Google Scholar 

  4. Agro AS (1999) Meeting the challenge of chronic suppurative otitis media. Infect Dis Infoalert 20:1–9

    Google Scholar 

  5. Aimoni C, Pelucchi S, Grasso DL, Libanore M, Martini M (2005) Bacterial meningitis complicating suppurative otitis media and sinusitis. Otolaryngol Head Neck Surg 132:965–966

    PubMed  Google Scholar 

  6. Alonsodevelasco E, Verheul AFM, Verhoef J, Snippe H (1995) Streptococcus pneumoniae: virulence factors, pathogenesis, and vaccines. Microbiol Rev 59:591–603

    PubMed  CAS  Google Scholar 

  7. Amorena B, Gracia E, Monzon M (1999) Antibiotic susceptibility assay for Staphylococcus aureus in biofilms developed in vitro. J Antimicrob Chemother 44:43–55

    PubMed  CAS  Google Scholar 

  8. Appelbaum PC (1992) Antimicrobial resistance in Streptococcus pneumoniae. Clin Infect Dis 15:77–83

    PubMed  CAS  Google Scholar 

  9. Appelbaum PC (1995) New prospects for antibacterial agents against multidrug-resistant pneumococci. Microb Drug Resist 1:43–48

    PubMed  CAS  Google Scholar 

  10. Bamberger DM, Jackson MA (2001) Upper respiratory tract infections: pharyngitis, sinusitis, otitis media, and epiglottitis. In: Niederman MS, Sarosi GA, Glassroth J (eds) Respiratory infections, 2nd edn. Lippincott Williams and Wilkens, Philadelphia, pp 125–139

    Google Scholar 

  11. Barden LS, Dowell SF, Schwartz B, Lackey C (1998) Current attitudes regarding use of antimicrobial agents: results from physicians’ and parents’ focus group discussions. Clin Pediatr (Phila) 37:665–671

    CAS  Google Scholar 

  12. Bellomo G, Mangiagle A, Nicastro L, Frigerio G (1980) A controlled double-blind study of SF68 strain as a new biological preparation for the treatment of diarrhoea in paediatrics. Curr Ther Res Clin Exp 28:927–934

    Google Scholar 

  13. Benyacoub J, Czarnecki-Maulden GL, Sauthier C, Anderson RE, Schiffrin EJ, Von der Weid T (2003) Supplementation of food with Enterococcus faecium (SF68) stimulates immune functions in young dogs. J Nutr 133:1158–1162

    PubMed  CAS  Google Scholar 

  14. Bernstein JM (1999) Waldeyer’s ring and otitis media: the nasopharyngeal tonsil and otitis media. Int J Pediatr Otorhinolaryngol 49:127–132

    Google Scholar 

  15. Bernstein JM, Faden HF, Dryja DM, Wactawski-Wende J (1993) Micro-ecology of the nasopharyngeal bacterial flora in otitis-prone and non-otitis-prone children. Acta Otolaryngol 113:88–92

    PubMed  CAS  Google Scholar 

  16. Bernstein JM, Sagahtaheri-Altaie S, Dryjd DM, Wactawski-Wende J (1994) Bacterial interference in nasopharyngeal bacterial flora of otitis-prone and non-otitis-prone children. Acta otolaryngol, Belgium 48:1–9

    CAS  Google Scholar 

  17. Bierbaum G, Brötz H, Koller KP, Sahl HG (1995) Cloning, sequencing and production of the lantibiotic mersacidin. FEMS Microbiol Lett 127:121–126

    PubMed  CAS  Google Scholar 

  18. Block SL, Hedrick J, Harrison CJ (2004) Community-wide vaccination with heptavalent pneumococcal conjugate significantly alters the microbiology of acute otitis media. Pediatr Infect Dis J 23:829–833

    PubMed  Google Scholar 

  19. Blomgren K, Pitkäranta A (2003) Is it possible to diagnose acute otitis media accurately in primary health care? Fam Pract 20(5):524–527

    PubMed  Google Scholar 

  20. Blomgren K, Pitkäranta A (2005) Current challenges in diagnosis of acute otitis media. Int J Pediatr Otorhinolaryngol 69:295–299

    PubMed  Google Scholar 

  21. Breukink E, De Kruijff B (1999) The lantibiotic nisin, a special case or not? Biochim Biophys Acta 1462:223–234

    PubMed  CAS  Google Scholar 

  22. Brogden KA (2005) Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria? Nature Rev. Microbiol 3:238–250

    CAS  Google Scholar 

  23. Brook I (2003) Effects of antimicrobial therapy on the microbial flora of the adenoids. J Antimicrob Chemother 51:1331–1337

    PubMed  CAS  Google Scholar 

  24. Brook I (2005) The role of bacterial interference in otitis, sinusitis, and tonsillitis. Otolaryngol Head Neck Surg 133:139–146

    PubMed  Google Scholar 

  25. Brook I, Foote PA (1997) Bacterial interference and beta-lactamase-producing bacteria in the adenoids after antimicrobial therapy. Rev Infect Dis 25:493

    Google Scholar 

  26. Brook I, Gober AE (1998) Bacterial interference in the nasopharynx following antimicrobial therapy of acute otitis media. J Antimicrob Chemother 41:489–492

    PubMed  CAS  Google Scholar 

  27. Brook I, Gober AE (2000) In vitro bacterial interference in the nasopharynx of otitis media-prone and non-otitis media-prone children. Arch Otolaryngol Head Neck Surg 126:1011–1013

    PubMed  CAS  Google Scholar 

  28. Brook I, Gober AE (2005) Antimicrobial resistance in the nasopharyngeal flora of children with acute otitis media and otitis media recurring after amoxicillin therapy. J Med Microbiol 54:83–85

    PubMed  CAS  Google Scholar 

  29. Brook I, Gober AE (2005) Long-term effects on the nasopharyngeal flora of children following antimicrobial therapy of acute otitis media with cefdinir or amoxicillin-clavulanate. J Med Microbiol 54:553–556

    PubMed  CAS  Google Scholar 

  30. Brook I, Yocum P (1999) Bacterial interference in the adenoids of otitis media-prone children. Pediatr Infect Dis J 18:835–837

    PubMed  CAS  Google Scholar 

  31. Bruno MEC, Montville TJ (1993) Common mechanistic action of bacteriocins from lactic acid bacteria. Appl Environ Microbiol 59:3003–3010

    PubMed  CAS  Google Scholar 

  32. Casey JR, Pichichero ME (2004) Changes in frequency and pathogens causing acute otitis media in 1995–2003. Pediatr Infect Dis J 23:824–828

    PubMed  Google Scholar 

  33. Cayé-Thomasen P, Tos M (2004) Eustachian tube gland tissue changes are related to bacterial species in acute otitis media. Int J Pediatr Otolaryngol 68:101–110

    Google Scholar 

  34. Chatterjee C, Paul M, Xie L, Van der Donk WA (2005) Biosynthesis and mode of action of lantibiotics. Chem Rev 105:633–684

    PubMed  CAS  Google Scholar 

  35. Chen Y, Shapira R, Eisenstein M, Montville TJ (1997) Functional characterization of pediocin PA-1 binding to liposomes in the absence of a protein receptor and its relationship to a predicted tertiary structure. Appl Environ Microbiol 63:524–531

    PubMed  CAS  Google Scholar 

  36. Chikindas ML, García-Garcerá MJ, Driessen AJM, Ledeboer AM, Nissen-Meyer J, Nes IF, Abee T, Konings WN, Venema G (1993) Pediocin PA-1, a bacteriocin from Pediococcus acidilactici PAC1.0, forms hydrophilic pores in the cytoplasmic membrane of target cells. Appl Environ Microbiol 59:3577–3584

    PubMed  CAS  Google Scholar 

  37. Cleveland J, Montville TJ, Nes IF, Chikindas ML (2001) Bacteriocins: safe, natural antimicrobials for food preservation. Int J Food Microbiol 71:1–20

    PubMed  CAS  Google Scholar 

  38. Cotter PD, Hill C, Ross RP (2005) Bacteriocins: developing innate immunity for food. Nat Rev Microbiol 3:777–788

    PubMed  CAS  Google Scholar 

  39. Cripps AW, Otczyk DC, Kyd JM (2005) Bacterial otitis media: a vaccine preventable disease? Vaccine 23:2304–2310

    PubMed  Google Scholar 

  40. Dagan R, Leibovitz E (2002) Bacterial eradication in the treatment of otitis media. Lancet Infect Dis 2:593–604

    PubMed  Google Scholar 

  41. Dagan R, Sikuler-Cohen M, Zamir O, Janco J, Givon-Lavi N, Fraser D (2001) Effect of a conjugate pneumococcal vaccine on the occurrence of respiratory infections and antibiotic use in day-care center attendees. Pediatr Infect Dis J 20:951–958

    PubMed  CAS  Google Scholar 

  42. De Gutierrez RC, Santos V, Nader-Macias ME (2001) Protective effect of intranasally inoculated Lactobacillus fermentum against Streptococcus pneumoniae challenge on the mouse respiratory tract. FEMS Immunol Med Microbiol 31:187–195

    Google Scholar 

  43. De Ru JA, Grote JJ (2004) Otitis media with effusion: disease or defence? Int J Pediatr Otorhinolaryngol 68:331–339

    PubMed  Google Scholar 

  44. De Vuyst L, Vandamme EJ (1994) Antimicrobial potential of lactic acid bacteria. In: De Vuyst L, Vandamme EJ (eds) Bacteriocins of lactic acid bacteria: microbiology, genetics and application. Blackie Academic and Professional, London, pp 91–142

    Google Scholar 

  45. Delves-Broughton J, Blackburn P, Evans RJ, Hugenholtz J (1996) Applications of the bacteriocin, nisin. Antonie Van Leeuwenhoek 69:193–202

    PubMed  CAS  Google Scholar 

  46. Dierksen K, Tagg J (2000) The influence of indigenous bacteriocin-producing Streptococcus salivarius on the acquisition of Streptococcus pyogenes by primary school children in Dunedin, New Zealand. In: Martin D, Tagg J (eds) Streptococci and streptococcal disease entering the new millennium. Securacopy, Wellington, New Zealand, pp 81–85

    Google Scholar 

  47. Dowell SF, Butler JC, Giebink GS, Jacobs MR, Jernigan D, Musher D, Rakowsky A, Schwartz B (1999) Acute otitis media: management and surveillance in an era of pneumococcal resistance—a report from the drug-resistant Streptococcus pneumoniae therapeutic working group. Pediatr Infect Dis J 18:1–9

    PubMed  CAS  Google Scholar 

  48. Eijsink VG, Skeie M, Middelhoven PH, Brurberg MB, Nes IF (1998) Comparative studies of class IIa bacteriocins of lactic acid bacteria. Appl Environ Microbiol 64:3275–3281

    PubMed  CAS  Google Scholar 

  49. Eneli IU (1998) Otitis media: an update. Med Update Psychiatr 3:165–169

    Google Scholar 

  50. Ennahar S, Sashihara T, Sonomoto K, Ishizaki A (2000) Class IIa bacteriocins: biosynthesis, structure and activity. FEMS Microbiol Rev 24:85–106

    PubMed  CAS  Google Scholar 

  51. Erdosa G, Sayeeda S, Antalisa P, Hua FZ, Hayesa J, Goodwina J, Dopicoa R, Posta C, Ehrlicha GD (2003) Development and characterization of a pooled Haemophilus influenzae genomic library for the evaluation of gene expression changes associated with mucosal biofilm formation in otitis media. Int J Pediatr Otorhinolaryngol 67:749–755

    Google Scholar 

  52. Faden H, Duffy L, Wasielewski R (1997) Relationship between nasopharyngeal colonization and the development of otitis media in children. J Infect Dis 175:1440–1445

    Article  PubMed  CAS  Google Scholar 

  53. Farrell D, Klugman K, Pichichero M (2007) Increased antimicrobial resistance among nonvaccine serotypes of Streptococcus pneumoniae in the pediatric population after the introduction of 7-Valent Pneumococcal Vaccine in the United States. Pediatr Infect Dis J 26:123–128

    PubMed  Google Scholar 

  54. Fendrick AM, Saint S, Brook I, Jacobs MR, Pelton S, Sethi S (2001) Diagnosis and treatment of upper respiratory tract infections in the primary care setting. Clin Ther 23(10):1683–1706

    PubMed  CAS  Google Scholar 

  55. Fimland G, Blingsmo OR, Sletten K, Jung G, Nes IF, Nissen-Meyer J (1996) New biologically active hybrid bacteriocins constructed by combining regions from various pediocin-like bacteriocins: the C-terminal region is important for determining specificity. Appl Environ Microbiol 62:3313–3318

    PubMed  CAS  Google Scholar 

  56. Fleury Y, Dayem MA, Montagne JJ, Chaboisseau E, Le Caer JP, Nicolas P, Delfour A (1996) Covalent structure, synthesis, and structure-function studies of mesentericin Y 10537, a defensive peptide from Gram-positive bacteria Leuconostoc mesenteroides. J Biol Chem 271:14421–14429

    PubMed  CAS  Google Scholar 

  57. Fluit AC, Visser MR, Schmitz F-J (2001) Molecular detection of antimicrobial resistance. Clin Microbiol Rev 14(4):836–871

    PubMed  CAS  Google Scholar 

  58. Fregeau Gallagher NL, Sailer M, Niemczura WP, Nakashima TT, Stiles ME, Vederas JC (1997) Three-dimensional structure of leucocin A in trifluoroethanol and dodecylphosphocholine micelles: spatial location of residues critical for biological activity in type IIa bacteriocins from lactic acid bacteria. Biochem 36:15062–15072

    CAS  Google Scholar 

  59. Fujimori I, Hisamatsu K, Kikushima K, Goto R, Murakami Y, Yamada T (1996) The nasopharyngeal bacterial flora in children with otitis media with effusion. Eur Arch Otorhinolaryngol 253(4–5):260–263

    PubMed  CAS  Google Scholar 

  60. Giacometti A, Cirioni O, Del Prete MS, Paggi AM, D’Errico MM, Scalise G (2000) Combination studies between polycationic peptides and clinically used antibiotics against Gram-positive and Gram-negative bacteria. Peptides 21:1155–1160

    PubMed  CAS  Google Scholar 

  61. Giraffa G, Carminati D, Neviani E (1997) Enterococci isolated from diary products: a review of risks and potential technological use. J Food Protect 60:732–738

    Google Scholar 

  62. Gould IM (1998) Antibiotic policies and control of resistance. Curr Opin Infect Dis 15:395–400

    Google Scholar 

  63. Hancock RE, Patrzykat A (2002) Clinical development of cationic antimicrobial peptides: from natural to novel antibiotics. Curr Drug Targets Infect Disord 2:79–83

    PubMed  CAS  Google Scholar 

  64. Hansman D, Bullen MM (1967) A resistant pneumococcus (Letter). Lancet 2:264–265

    Google Scholar 

  65. Hatakkaa K, Blomgrenc K, Pohjavuoria S, Kaijalainene T, Poussaf T, Leinonene M, Korpelaa R, Pitka A (2007) Treatment of acute otitis media with probiotics in otitis-prone children -a double-blind, placebo-controlled randomised study. Clin Nutr 26:314–321

    Google Scholar 

  66. Heikkinen T, Thint M, Chonmaitree T (1999) Prevalence of various respiratory viruses in the middle ear during acute otitis media. N Engl J Med 340(4):260–264

    PubMed  CAS  Google Scholar 

  67. Hicks LA, Harrison LH, Flannery B, Hadler JL, Schaffner W, Craig AS (2007) Incidence of pneumococcal disease due to non-pneumococcal conjugate vaccine (PCV7) serotypes in the United States during the era of widespread PCV7 vaccination, 1998–2004. J Infect Dis 196:1346–1354

    PubMed  Google Scholar 

  68. Homblé F, Cabiaux V, Ruysschaert J (1998) Channel or channel-like activity associated with pore-forming proteins or peptides? Mol Microbiol 27:1261–1263

    PubMed  Google Scholar 

  69. Homoe P, Christensen RB, Bretlau P (2005) Acute otitis media and season of birth. Int J Pediatr Otorhinolaryngol 69:487–491

    PubMed  Google Scholar 

  70. Huebner RE, Wasas AD, Klugman KP (2000) Trends in antimicrobial resistance and serotyoe distribution of blood and cerebrospinal fluid isolates of Streptotcoccus pneumoniae in South Africa, 1991–1998. Int J Infect Dis 4(4):214–218

    PubMed  Google Scholar 

  71. Ingham AB, Ford M, Moore RJ, Tizard M (2003) The bacteriocin piscicolin 126 retains antilisterial activity in vivo. J Antimicrob Chemother 51:1365–1371

    PubMed  CAS  Google Scholar 

  72. Jack RW, Sahl HG (1995) Unique peptide modifications involved in the biosynthesis of lantibiotics. Trends Biotechnol 13:269–278

    PubMed  CAS  Google Scholar 

  73. Jack RW, Tagg JR, Ray B (1995) Bacteriocins of Gram-positive bacteria. Microbiol Rev 59:171–200

    PubMed  CAS  Google Scholar 

  74. Jacobs MRJ (2004) Streptococcus pneumoniae: epidemiology and patterns of resistance. Am J Med 117(3A):3S–15S

    PubMed  CAS  Google Scholar 

  75. Jacobs MRJ, Bajaksouzian S, Windau A, Good CE, Lin G, Pankuck GA, Appelbaum PC (1999) Susceptibility of Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis to oral agents: results of a 1998 US outpatient surveillance study. Presented at: 39th Interscience Conference on Antimicrobial Agents and Chemotherapy; September 26–29, San Francisco, CA

  76. Jones ME, Blosser-Middleton RS, Thornsberry C, Karlowsky JA, Sahm DF (2003) The activity of levofloxacin and other antimicrobials against clinical isolates of Streptococcus pneumoniae collected worldwide during 1999–2002. Diagn Microbiol Infect Dis 47:579–586

    PubMed  CAS  Google Scholar 

  77. Kaieda S, Yano H, Okitsu N, Hosaka Y, Okamoto R, Inoue M, Takahashi H (2005) Investigation about the homogeneity of nasopharyngeal microflora at the different location of nasopharynx of children with acute otitis media. Int J Pediatr Otorhinolaryngol 69:959–963

    PubMed  Google Scholar 

  78. Kawano H, Haruta A, Tsuboi Y, Kim Y, Schchern PA, Paparella MM, Lin J (2002) Induction of mucus cell metaplasia by tumor necrosis factor alpha in rat middle ear: the pathological basis for mucin hyperproduction in mucoid otitis media. Ann Otol Rhinol Laryngol 111:415–422

    PubMed  Google Scholar 

  79. Klaenhammer TR (1993) Genetics of bacteriocins produced by lactic acid bacteria. FEMS Microbiol Rev 12:39–86

    PubMed  CAS  Google Scholar 

  80. Kleemola M, Nokso-Koivisto J, Herva E, Syrjänen R, Lahdenkari M, Kilpi T, Hovi T (2006) Is there any specific association between respiratory viruses and bacteria in acute otitis media of young children? J Infect 52(3):181–187

    PubMed  Google Scholar 

  81. Klein JO (1999) Management of acute otitis media in an era of an increasing antibiotic resistance. Int J Pediatr Otorhinolaryngol 49(1):S15–S17

    PubMed  Google Scholar 

  82. Klugman KP, Koornhof HJ (1988) Drug resistance patterns and serotypes of pneumococcal isolates from cerebrospinal fluid or blood, 1979–1986. J Infect Dis 158:956–964

    PubMed  CAS  Google Scholar 

  83. Knoetze H, Todorov SD, Dicks LMT (2008) A class IIa peptide from Enterococcus mundtii inhibits bacteria associated with Otitis Media. Int J Antimicrob Agents 31:228–234

    PubMed  CAS  Google Scholar 

  84. Koornhof HJ, Wasas A, Klugman K (1992) Antimicrobial resistance in Streptococcus pneumoniae: a South Africa perspective. Clin Infect Dis 15:84–94

    PubMed  CAS  Google Scholar 

  85. Kouwen H, van Balen FAM, Dejonkere PH (2005) Functional tube therapy for persistent otitis media with effusion in children: myth or evidence? Int J Pediatr Otorhinolaryngol 69:943–951

    PubMed  CAS  Google Scholar 

  86. Lee DH, Park YS, Jung TT, Yeo SW, Choi YC, Jeon E (2001) Effect of tumor necrosis factor-alpha on experimental otitis media with effusion. Laryngoscope 111:728–733

    PubMed  CAS  Google Scholar 

  87. Leibovitz E, Dagan R (2000) Antibiotic treatment for acute otitis media. Int J Antimicrob Agents 15:169–177

    PubMed  CAS  Google Scholar 

  88. Leibovitz E, Dagan R (2001) Otitis media therapy and drug resistance. Part 1: management principles. Infect Med 18:212–216

    Google Scholar 

  89. Leibovitz E, Dagan R (2001) Otitis media therapy and drug resistance. Part 2: current concepts and new directions. Infect Med 18:263–270

    Google Scholar 

  90. Lewenstein A, Frigerio G, Moroni M (1979) Biological properties of SF68, a new approach for the treatment of diarrhoeal diseases. Curr Ther Res Clin Exp 26:967–981

    CAS  Google Scholar 

  91. Lieberthal AS, Ganiats TG, Cox EO, Culpepper L, Mahoney M, Miller D, Runyan DK, Shapiro NL, Wald E (2004) Diagnosis and management of acute otitis media. Clinical practical guidelines. Pediatrics 113(5):1451–1465

    Google Scholar 

  92. Low DE (2001) Mechanisms of antimicrobial resistance. In: Niederman MS, Sarosi GA, Glassroth J (eds) Respiratory infections, 2nd edn. Lippincott Williams and Wilkens, Philadelphia, pp 93–107

    Google Scholar 

  93. McCracken GH (2002) Diagnosis and management of acute otitis media in the urgent care setting. Ann Emerg Med 39:413–421

    PubMed  Google Scholar 

  94. McEllistrem MC, Adams JM, Patel K, Mendelsohn AB, Kaplan SL, Bradley JS (2005) Acute otitis media due to penicillin-nonsusceptible Streptococcus pneumoniae before and after the introduction of the pneumococcal conjugate vaccine. Clin Infect Dis 40:1738–1744

    PubMed  Google Scholar 

  95. Miller KW, Schamber R, Osmanagaoglu O, Ray B (1998) Isolation and characterization of pediocin AcH chimeric protein mutants with altered bactericidal activity. Appl Environ Microbiol 64:1997–2005

    PubMed  CAS  Google Scholar 

  96. Moll GN, Konings WN, Driessen AJM (1999) Bacteriocins: mechanism of membrane insertion and pore formation. Antonie Van Leeuwenhoek 76:185–198

    PubMed  CAS  Google Scholar 

  97. Montgomery D (2005) A new approach to treating acute otitis media. J Pediatr Health Care 19(1):50–52

    PubMed  Google Scholar 

  98. Montville TJ, Chen Y (1998) Mechanistic action of pediocin and nisin: recent progress and unresolved questions. Appl Microbiol Biotechnol 50:511–519

    PubMed  CAS  Google Scholar 

  99. Moreno MRF, Sarantinopoulos P, Tsakalidou E, de Vuyst L (2005) The role and application of enterococci in food and health. Int J Food Microbiol 106(1):1–24

    Google Scholar 

  100. Munguia R, Daniel SJ (2008) Ototopical antifungals and otomycosis: a review. Int J Pediatr Otorhinolaryngol 72:453–459

    PubMed  Google Scholar 

  101. Munoz RT, Coffey J, Daniels M, Dowson CG, Laible G, Casal J, Hakenbeck R, Jacobs M, Musser JM, Spratt BG (1991) Inter-continental spread of a multiresistant clone of serotype 23F Streptococcus pneumoniae. J Infect Dis 164:302–306

    PubMed  CAS  Google Scholar 

  102. Murphy TF, Bakeletz LO, Kyd JM, Watson B, Klein DL (2005) Vaccines for otitis media: proposals for overcoming obstacles to progress. Vaccine 23:2696–2702

    PubMed  CAS  Google Scholar 

  103. Nigrovic LE, Kuppermann N, Malley R (2008) Children with bacterial meningitis presenting to the emergency department during the pneumococcal conjugate vaccine era. Acad Emerg Med 15:522–528

    PubMed  Google Scholar 

  104. Nissen-Meyer J, Holo H, Håvarstein LS, Sletten K, Nes IF (1992) A novel lactococcal bacteriocin whose activity depends on the complementary action of two peptides. J Bacteriol 174:5686–5692

    PubMed  CAS  Google Scholar 

  105. Nokso-Koivisto J, Raty R, Blomqvist S, Kleemola M, Syrjanen R, Pitkaranta A, Kilpi T, Hovi T (2004) Presence of specific viruses in the middle ear fluids and respiratory secretions of young children with acute otitis media. J Med Virol 72(2):241–248

    PubMed  Google Scholar 

  106. Peltola V, Waris M, Österbackb R, Susib P, Hyypiäb T, Ruuskanena O (2008) Clinical effects of rhinovirus infections. J Clin Virol 43:411–414

    PubMed  Google Scholar 

  107. Penido NDO, Borin A, Iha LCN, Suguri VM, Onishi E, Fukuda Y, Cruz OLM (2005) Intracranial complications of otitis media: 15 years of experience in 33 patients. Otolaryngol Head Neck Surg 132(1):37–42

    Google Scholar 

  108. Pichichero ME (2000) Acute otitis media. Part 1. Improving diagnostic accuracy. Am Fam Physician 61(8):2051–2056

    PubMed  CAS  Google Scholar 

  109. Pichichero ME (2000) Acute otitis media. Part 2. Treatment in an era of increasing antibiotic resistance. Am Fam Physician 61(8):2410–2418

    PubMed  CAS  Google Scholar 

  110. Pichichero ME, Casey JR (2007) Emergence of a multiresistant serotype 19A pneumococcal strain not included in the 7-valent conjugate vaccine as an otopathogen in children. JAMA 298:1772–1778

    PubMed  CAS  Google Scholar 

  111. Pitcher PA, Carr MM, Clarke KD (1997) Care of the child with tympanostomy tubes: a guide for the primary care physician. Dalhousie Med J http://medjournal.medicine.dal.ca/DMJONLIN/winter97/orig7.htm. Accessed 27 January 2009

  112. Post JC, Stoodley P, Hall-Stoodley L (2004) The role of biofilms in otolaryngologic infections. Curr Opin Otolaryngol Head Neck Surg 12:185–190

    PubMed  Google Scholar 

  113. Potera C (1999) Forging a link between biofilms and disease. Science 283:1837–1839

    PubMed  CAS  Google Scholar 

  114. Quadri LEN, Kleerebezem M, Kuipers OP, de Vos WM, Roy KL, Vederas JC, Stiles ME (1997) Characterization of a locus from Carnobacterium piscicola LV17B involved in bacteriocin production and immunity: evidence for global inducer-mediated transcriptional regulation. J Bacteriol 179:6163–6171

    PubMed  CAS  Google Scholar 

  115. Reddy MS, Bernstein JM, Murphy TF, Faden HS (1996) Binding between outer membrane proteins of non-typable Haemophilus influenzae and human nasopharyngeal mucin. Infect Immunol 64:1477–1479

    CAS  Google Scholar 

  116. Reinert RR (2004) Pneumococcal conjugate vaccines—a European perspective. Int J Med Microbiol 294:277–294

    PubMed  CAS  Google Scholar 

  117. Riley MA, Wertz JE (2002) Bacteriocins: evolution, ecology, and application. Ann Rev Microbiol 56:117–137

    CAS  Google Scholar 

  118. Roos K, Hakansson EG, Holm S (2001) Effect of recolonisation with “interfering” alpha streptococci on recurrences of acute and secretory otitis media in children: randomised placebo controlled trail. BMJ 322:210–212

    PubMed  CAS  Google Scholar 

  119. Rosenfeld RM, Bluestone CD (1999) Evidence based otitis media. BC Becker Inc., St Louis, MO

    Google Scholar 

  120. Rosenfeld RM, Culpepper L, Doyle KJ, Grundfast KM, Hoberman A, Kenna MA, Lieberthal AS, Mahoney M, Wahl RA, Woods CR Jr, Yawn BL (2004) Clinical practice guideline: otitis media with effusion. Otolaryngol Head Neck Surg 130:S95–S118

    PubMed  Google Scholar 

  121. Ryan MP, Flynn J, Hill C, Ross RP, Meaney WJ (1999) The natural food grade inhibitor, Lacticin 3147, reduced the incidence of mastitis after experimental challenge with Streptococcus dysgalactiae in non-lactating dairy cows. J Dairy Sci 82:2625–2631

    Article  PubMed  CAS  Google Scholar 

  122. Sahm DF, Jones ME, Hickey ML, Diakun DR, Mani SV, Thornsberry C (2000) Resistance surveillance of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis isolated in Asia and Europe 1997–1998. J Antimicrob Chemother 45:457–466

    PubMed  CAS  Google Scholar 

  123. Schousboe LP, Ovesen T, Eckardt L, Rasmussen LM, Pedersen CB (2001) How does endotoxin trigger inflammation in otitis media with effusion? Laryngoscope 111:279–300

    Google Scholar 

  124. Segal N, Leibovitz E, Dagan R, Leiberman A (2005) Acute otitis media-diagnosis and treatment in the era of antibiotic resistant bacteria: updated clinical practice guidelines. Int J Otorhinolaryngol 69:1311–1319

    Google Scholar 

  125. Seppälä H, Klaukka T, Vuopio-Varkila J, Muotiala A, Helenius H, Lager K, Huovinen P (1997) The effect of changes in the consumption of macrolide antibiotics on erythromycin resistance in group A streptococci in Finland. N Engl J Med 337:441–446

    PubMed  Google Scholar 

  126. Sibold C, Wang J, Henrichsen J, Hakenbeck R (1992) Genetic relationship of penicillin-susceptible and -resistant Streptococcus pneumoniae strains isolated from different continents. Infect Immun 60:4119–4126

    PubMed  CAS  Google Scholar 

  127. Smirnova MG, Birchall JP, Pearson JP (2002) In vitro study of IL-8 and goblet cells: possible role of IL-8 in the aetiology of otitis media with effusion. Acta Otolaryngol 122:146–152

    PubMed  CAS  Google Scholar 

  128. Sokos DR (2005) Pharmacists’ role in increasing pneumococcal and influenza vaccination. Am J Health Syst Pharm 62:367–377

    PubMed  Google Scholar 

  129. Spiro DM, Tay K, Baker MD, Arnold DH, Shapiro ED (2005) Wait-and-see antibiotic prescription for the treatment of acute otitis media: a randomized controlled trial. Acad Emerg Med 12(5):19

    Google Scholar 

  130. Stein CR, Weber DJ, Kelley M (2003) Using hospital antibiogram data to assess regional pneumococcal resistance to antibiotics. Emerg Infect Dis 2:211–216

    Google Scholar 

  131. Tagg JR, Dierksen KP (2003) Bacterial replacement therapy: adapting ‘germ warfare’ to infection prevention. Trends Biotechnol 21:217–223

    PubMed  CAS  Google Scholar 

  132. Tano K, Olofsson C, Grahn-Hǻkansson E, Holm SE (1999) In vitro inhibition of S. pneumoniae, non-typeable H. influenzae and M. catarrhalis by alpha-haemolytic streptococci from healthy children. Int J Pediatr Otorhinolaryngol 47:49–56

    PubMed  CAS  Google Scholar 

  133. Tano K, Grahn-Hǻkansson E, Holm SE, Hellström S (2000) Inhibition of OM pathogens by alpha-hemolytic streptococci from healthy children, children with SOM and children with rAOM. Int J Pediatr Otorhinolaryngol 56:185–190

    PubMed  CAS  Google Scholar 

  134. Tano K, Grahn-Hǻkansson E, Holm SE, Hellström S (2002) A nasal spray with alpha-haemolytic streptococci as long-term prophylaxis against recurrent otitis media. Int J Pediatr Otorhinolaryngol 62:17–23

    PubMed  Google Scholar 

  135. Todorov SD, Wachsman MB, Knoetze H, Meincken M, Dicks LMT (2005) An antibacterial and antiviral peptide produced by Enterococcus mundtii ST4 V isolated from soya beans. Int J Antimicrob Agents 25:508–513

    PubMed  CAS  Google Scholar 

  136. Turner D, Leibovitz E, Aran A, Piglansky L, Raiz S, Leiberman A, Alberto D (2002) Acute otitis media in infants younger than two months of age: microbiology, clinical presentation and therapeutic approach. Pediatr Infect Dis J 21(7):669–674

    PubMed  Google Scholar 

  137. Underdahl NR (1983) The effect of feeding Streptococcus faecium upon Escherichia coli induced diarrhoea in gnotobiotic pigs. Prog Food Nutr Sci 7:5–12

    PubMed  CAS  Google Scholar 

  138. Van Kempen MJP, Vermeiren JS, Vaneechoutte M, Claeys G, Veenhoven RH, Rijkers GT, Sanders EAM, Dhooge IJ (2005) Pneumococcal conjugate vaccination in children with recurrent acute otitis media: a therapeutic alternative? Int J Pediatr Otorhinolaryngol 70(2):275–285

    PubMed  Google Scholar 

  139. Wachsman MB, Farias ME, Takeda E, Sesma F, De Ruiz Holgado AP, de Torres RA, Coto CE (1999) Antiviral activity of enterocin CRL against herpes virus. Int J Antimicrob Agents 12:293–299

    PubMed  CAS  Google Scholar 

  140. Wachsman MB, Castilla V, De Ruiz Holgado AP, de Torres RA, Sesma F, Coto CE (2003) Enterocin CRL35 inhibits late stages of HSV-1 and HSV-2 replication in vitro. Antiviral Res 58:17–24

    PubMed  CAS  Google Scholar 

  141. Walls T, Power D, Tagg J (2003) Bacteriocin-like substance (BLIS) production by the normal flora of the nasopharynx: potential to protect against otitis media? J Med Microbiol 52:829–833

    PubMed  CAS  Google Scholar 

  142. Whitney CG, Farley MM, Hadler J, Harrison LH, Lexau C, Reingold A, Lefkowitz L, Cieslak PR, Zell ER, Jorgensen JH, Schuchat A (2000) Increasing prevalence of multidrug-resistant Streptococcus pneumoniae in the United States. New Eng J Med 343:1917–1924

    PubMed  CAS  Google Scholar 

  143. Wiedemann I, Breukink E, van Kraaij C, Kuipers OP, Bierbaum G, de Kruijff B, Sahl H-G (2001) Specific binding of nisin to peptidoglycan precursor lipid II combines pore formation and inhibition of cell wall biosynthesis for potent antibiotic activity. J Biol Chem 276:1772–1779

    PubMed  CAS  Google Scholar 

  144. Witte W (1999) Antibiotic resistance in Gram-positive bacteria: epidemiological aspects. J Antimicrob Chemother 44:1–9

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Microbiology, University of Stellenbosch, Private Bag X1, 7602, Matieland (Stellenbosch), South Africa

    L. M. T. Dicks, H. Knoetze & C. A. van Reenen

Authors
  1. L. M. T. Dicks
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. H. Knoetze
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. C. A. van Reenen
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to L. M. T. Dicks.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Dicks, L.M.T., Knoetze, H. & van Reenen, C.A. Otitis Media: A Review, with a Focus on Alternative Treatments. Probiotics & Antimicro. Prot. 1, 45–59 (2009). https://doi.org/10.1007/s12602-009-9008-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12602-009-9008-9

Keywords

Search

Navigation